Addison vs. Cushing Syndrome — Addison disease vs Cushing syndrome pathophysiology

The clinical recognition of adrenal gland disorders represents a pivotal chapter in the history of endocrinology. Before the biochemical identity of cortisol was established, astute clinicians noticed that certain patients exhibited dramatic changes in skin pigmentation, body habitus, and metabolic stability that could be traced to the small, triangular glands perched atop the kidneys. The paired conditions now known as Addison disease and Cushing syndrome emerged from careful clinical observation decades apart, each illuminating a different facet of the hypothalamic-pituitary-adrenal (HPA) axis. Together, they demonstrate how a single hormone — cortisol — can produce diametrically opposite clinical pictures depending on whether the body has too little or too much.

The fundamental question that unites these two syndromes is deceptively simple: what happens when the body's cortisol supply deviates drastically from its physiological set point? Addison disease answers this from the perspective of deficiency, while Cushing syndrome answers it from the perspective of excess. Understanding the pathophysiology of each condition, and the feedback mechanisms they disrupt, is essential for any healthcare professional tasked with diagnosis, management, or patient education.

Before dissecting each disease individually, it is essential to anchor the discussion in the normal physiology of the HPA axis and the adrenal cortex. The hypothalamus secretes corticotropin-releasing hormone (CRH), which stimulates anterior pituitary corticotroph cells to release adrenocorticotropic hormone (ACTH). ACTH then travels through the systemic circulation to the zona fasciculata of the adrenal cortex, stimulating the synthesis and release of cortisol. Cortisol exerts a negative feedback loop on both the hypothalamus and the anterior pituitary, thereby regulating its own production. Disruption of any component of this axis — whether through destruction, neoplasia, or exogenous administration — produces one of the two cardinal adrenal syndromes.

The visual above is the conceptual cornerstone of distinguishing these two syndromes. In the normal HPA axis, cortisol completes a negative feedback loop that maintains homeostasis. In Addison disease, the adrenal cortex is destroyed — most commonly by autoimmune adrenalitis in developed countries — so cortisol plummets and the pituitary responds with markedly elevated ACTH. The ACTH molecule is cleaved from the same precursor peptide (proopiomelanocortin, POMC) that yields melanocyte-stimulating hormone (MSH), which explains the characteristic hyperpigmentation of primary adrenal insufficiency. Conversely, in Cushing syndrome, excess cortisol from any source drives the multisystem pathology of glucocorticoid excess, while the ACTH level varies depending on the etiology.

Addison Disease: Pathophysiology of Cortisol Deficiency

In primary adrenal insufficiency, destruction of greater than 90% of the adrenal cortex must occur before clinical insufficiency manifests. The zona fasciculata's failure leads to cortisol deficiency, the zona glomerulosa's failure leads to aldosterone deficiency, and the zona reticularis's failure leads to adrenal androgen deficiency. The most common cause in industrialized nations is autoimmune adrenalitis (approximately 80% of cases), often associated with other autoimmune conditions in autoimmune polyendocrine syndromes (APS). In developing nations, tuberculosis remains a leading cause. The downstream effects are profound: without cortisol, hepatic gluconeogenesis falters, leading to hypoglycemia; without aldosterone, the kidneys cannot adequately retain sodium or excrete potassium, resulting in hyponatremia and hyperkalemia; and vascular smooth muscle loses cortisol-mediated sensitivity to catecholamines, causing hypotension and cardiovascular collapse in acute adrenal crisis.

Cushing Syndrome: Pathophysiology of Cortisol Excess

Chronic glucocorticoid excess exerts catabolic effects on virtually every organ system. In protein metabolism, cortisol promotes proteolysis in skin, muscle, and connective tissue, producing the characteristic thin skin, easy bruising, violaceous striae, and proximal myopathy. In carbohydrate metabolism, cortisol stimulates hepatic gluconeogenesis and opposes insulin action in peripheral tissues, leading to hyperglycemia and insulin resistance that may progress to frank diabetes mellitus. In lipid metabolism, cortisol promotes lipogenesis in certain depots (face, dorsocervical, trunk) while mobilizing fat from extremities, producing the classic centripetal obesity with moon facies, buffalo hump, and supraclavicular fat pads. Cortisol's mineralocorticoid activity at high concentrations saturates 11β-hydroxysteroid dehydrogenase type 2, allowing cortisol to act on mineralocorticoid receptors and producing hypertension, hypokalemia, and metabolic alkalosis.

Causes of Adrenal Insufficiency

Causes and Classification of Cushing Syndrome

The diagnostic approach to suspected Cushing syndrome typically proceeds through three stages. First, confirm hypercortisolism using screening tests — the 24-hour urinary free cortisol, the late-night salivary cortisol, or the 1 mg overnight dexamethasone suppression test. Second, determine ACTH dependence by measuring a morning plasma ACTH level. Third, localize the source: for ACTH-dependent disease, perform pituitary MRI and, if inconclusive, bilateral inferior petrosal sinus sampling (BIPSS) to distinguish pituitary from ectopic sources. For ACTH-independent disease, adrenal CT or MRI identifies the lesion.

A solid grasp of Addison disease and Cushing syndrome provides the foundation for understanding several more complex endocrine concepts encountered in advanced pathophysiology and clinical endocrinology courses. The principles of negative feedback disruption, receptor cross-reactivity (cortisol acting on mineralocorticoid receptors), and the clinical significance of hormone precursor processing (POMC cleavage) extend into broader discussions of neuroendocrine regulation and oncologic paraneoplastic syndromes.

One particularly important advanced concept is the phenomenon of relative adrenal insufficiency in critical illness. Patients in the intensive care unit may have cortisol levels that appear numerically normal but are inadequate for the degree of physiological stress. The CORTICUS and ADRENAL trials investigated whether stress-dose hydrocortisone improves outcomes in septic shock, yielding nuanced results that continue to shape critical care practice guidelines. Understanding the foundational HPA axis physiology and the pathophysiology of Addison and Cushing is essential for interpreting these debates.